|
Real-time Estimate
Cboe BZX
17:45:47 03/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.295 USD | -2.08% |
|
-13.57% | +74.52% |
| 08-24 | Precision BioSciences, Inc. Commences Dosing In Phase 1/2 Function-Dmd Study | CI |
| 08-24 | Precision BioSciences Doses First Patient in Trial of Potential Duchenne Muscular Dystrophy Treatment | MT |
| Market Cap | 206M 177M 167M 152M 285M 19.43B 287M 1.98B 768M 9.93B 772M 755M 32.62B | P/E 2026 * |
-2.06x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 206M 177M 167M 152M 285M 19.43B 287M 1.98B 768M 9.93B 772M 755M 32.62B | EV / Sales 2026 * |
15.2x | EV / Sales 2027 * | 23.2x |
| Free-Float |
91.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DTIL | Delayed | |
CBOE
| DTIL | Real-time | |
|
Tradegate
| PBS0 | Real-time | |
|
Boerse Muenchen
| PBS0 | Real-time | |
|
Deutsche Boerse AG
| PBS0 | Delayed | |
|
Börse Stuttgart
| PBS0 | Delayed |
Last Transcript : Precision BioSciences, Inc.
| 1 day | -2.08% | ||
| 1 week | -13.57% | ||
| Current month | -4.97% | ||
| 1 month | +2.83% | ||
| 3 months | +20.20% | ||
| 6 months | +66.90% | ||
| Current year | +74.52% |
| 1 week | 7.23 |  | 8.43 |
| 1 month | 7 | | 9.34 |
| Current year | 3.53 | | 9.62 |
| 1 year | 3.53 | | 9.62 |
| 3 years | 3.53 | | 19.43 |
| 5 years | 3.53 | | 414 |
| 10 years | 3.53 | | 710.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 48 | 15/10/2021 |
Jeff Smith
CTO | Chief Tech/Sci/R&D Officer | 53 | 26/01/2006 |
Naresh Tanna
DFI | Director of Finance/CFO | 45 | 01/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Buehler
CHM | Chairman | 68 | 01/11/2020 |
Geno Germano
BRD | Director/Board Member | 65 | 10/03/2020 |
Stanley Frankel
BRD | Director/Board Member | 67 | 12/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/1/26 A | Other | Chief Financial Officer | 251,581 | 1.0451% | ||
| 8/1/26 A | Other | Controller/Auditor | 48,872 | 0.2030% | ||
| 8/1/26 A | Other | Chief Technology Officer | 236,188 | 0.9812% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.08% | -13.57% | +43.76% | -48.51% | 206M | |
| -0.60% | -1.56% | +1.51% | +16.94% | 50.14B | |
| +0.78% | -5.26% | +426.84% | +521.92% | 44.85B | |
| +0.72% | +0.84% | +43.32% | +19.78% | 43.43B | |
| -0.15% | -3.45% | +6.96% | +75.58% | 41.14B | |
| -0.90% | -3.67% | +14.26% | +48.44% | 32.92B | |
| +0.02% | +6.87% | - | - | 17.56B | |
| +0.19% | -3.00% | +23.27% | +123.76% | 16.55B | |
| +1.21% | +0.90% | +17.18% | +29.64% | 14.65B | |
| -0.66% | -2.84% | +77.41% | +40.97% | 13.93B | |
| Average | -0.21% | -1.99% | +72.72% | +92.06% | 27.54B | |
| Weighted average by Cap. | -0.01% | -1.22% | +91.46% | +127.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.48M 11.63M 10.96M 9.98M 18.66M 1.27B 18.8M 130M 50.35M 651M 50.64M 49.53M 2.14B | 8.88M 7.66M 7.21M 6.57M 12.28M 838M 12.38M 85.39M 33.14M 429M 33.33M 32.6M 1.41B |
| Net income | -94.18M -81.25M -76.54M -69.74M -130M -8.9B -131M -906M -352M -4.55B -354M -346M -14.94B | -96.95M -83.64M -78.79M -71.78M -134M -9.16B -135M -933M -362M -4.68B -364M -356M -15.38B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | $7.260 | -2.55% | 24,147 |
| 02/09/26 | $7.450 | -2.49% | 358,921 |
| 01/09/26 | $7.640 | 0.00% | 170,933 |
| 31/08/26 | $7.640 | -1.80% | 214,810 |
| 28/08/26 | $7.780 | -7.38% | 222,526 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DTIL Stock
Select your edition
All financial news and data tailored to specific country editions
